SOME ASPECTS OF DRUG ACTION - A COMPARISON WITH INTRAMOLECULAR PROCESSES OCCURRING IN PHARMACEUTICAL AND BIOCHEMICAL SYSTEMS

被引：9

作者：

SMITH, HJ

WILLIAMS, H

机构：

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1965年 / 17卷 / 10期

关键词：

D O I：

10.1111/j.2042-7158.1965.tb07573.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：601 / +

页数：1

相关论文

共 173 条

[1] ALDRIDGE WN, 1956, ANN REP CHEM SOC, V53, P294
[2] ELECTRON DONOR AND ACCEPTOR CAPACITY OF SOME HORMONES
ALLISON, AC
PEOVER, ME
GOUGH, TA
[J]. LIFE SCIENCES, 1962, (12) : 729 - 737
[3] BAER E, 1948, J BIOL CHEM, V175, P79
[4] Bailly MC, 1938, CR HEBD ACAD SCI, V206, P1902
[5] BAILLY MC, 1939, CR HEBD ACAD SCI, V208, P443
[6] POTENTIAL ANTICANCER AGENTS .66. NON-CLASSICAL ANTIMETABOLITES .3. 4-(IODOACETAMIDO)-SALICYLIC ACID, AN EXO-ALKYLATING IRREVERSIBLE INHIBITOR OF GLUTAMIC DEHYDROGENASE
BAKER, BR
LEE, WW
ROSS, LO
TONG, E
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1961, 83 (17) : 3713 - &
[7] FACTORS IN DESIGN OF ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS
BAKER, BR
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1964, 53 (04) : 347 - &
[8] NONCLASSICAL ANTIMETABOLITES .16. BRIDGE PRINCIPLE OF SPECIFICITY WITH ACTIVE SITE-DIRECTED IRREVERSIBLE INHIBITORS .7. DETECTION OF DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES BY MALEAMYL GROUP
BAKER, BR
ALUMAULA, PI
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (09) : 914 - &
[9] NONCLASSICAL ANTIMETABOLITES .12. BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS .5. DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES AS DETECTED BY CARBOPHENOXY GROUP
BAKER, BR
PATEL, RP
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (10) : 927 - &
[10] POTENTIAL ANTICANCER AGENTS .50. NON-CLASSICAL ANTIMETABOLITES .2. SOME FACTORS IN THE DESIGN OF EXO-ALKYLATING ENZYME INHIBITORS, PARTICULARLY OF LACTIC DEHYDROGENASE
BAKER, BR
LEE, WW
SKINNER, WA
MARTINEZ, AP
TONG, E
[J]. JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1960, 2 (06): : 633 - 657

← 1 2 3 4 5 6 7 8 9 10 →